Skip to main content

Purely Proteins Raises First-Round Venture Financing

NEW YORK, Nov. 26 (GenomeWeb News) - Purely Proteins of Cambridge, UK said late yesterday it had raised an initial round of venture financing, but did not disclose the amount of the financing.

 

The company's business involves purification of suites of human proteins, as well as drug discovery services for therapeutic targets of these proteins that brings together in silico and biochemical approaches, according to David Parry-Smith, COO.

 

The funding round was led by Avlar BioVentrues and Yorkshire Fund Managers.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.